News/BioSpace Industry Operations Survey 2025

How Biotech Companies Use Virtual Assistants for Conference Abstracts, Lab Supply Coordination, and BD Scheduling

SA Editorial Team·

The Administrative Burden Slowing Biotech Commercialization

Biotechnology companies operate under relentless dual pressure: advance the science and build the commercial infrastructure simultaneously. Researchers managing IND-enabling studies, toxicology packages, and proof-of-concept experiments are also expected to submit conference abstracts, track regulatory correspondence, coordinate lab supply procurement, and schedule business development meetings with potential licensing partners.

BioSpace's 2025 industry operations survey found that scientists at companies with fewer than 100 employees spend an average of 11 hours per week on administrative tasks — time that could be redirected to bench work or data analysis. Virtual assistants are increasingly the solution that bridges this gap.

Conference Abstract and Poster Submission Management

Major conferences such as AACR, ASHP, ASCO, and BIO require abstract submissions with precise formatting, co-author sign-offs, platform registrations, and submission portal navigation. Missing a deadline or submitting an incorrectly formatted abstract can cost a company a significant visibility opportunity.

A virtual assistant dedicated to conference operations tracks all open abstract windows, maintains a submission calendar, coordinates draft routing between scientific authors, manages portal account credentials, handles confirmation correspondence, and follows up on acceptance notifications. When a poster is accepted, the VA coordinates printing logistics, shipping timelines, and presenter travel arrangements.

Lab Supply Ordering Coordination

Biotech labs run on consumables — reagents, disposables, cold chain materials, equipment maintenance contracts — and procurement coordination is a persistent time sink. A VA supports lab operations by managing vendor catalogs, submitting purchase orders through internal approval workflows, tracking order status and delivery confirmations, following up on backorders, and maintaining approved vendor lists for compliance purposes.

This is distinct from scientific procurement decision-making, which remains with researchers. The VA handles the administrative execution after decisions are made, reducing the back-and-forth that delays order fulfillment.

Regulatory Filing Tracking and Correspondence Management

For companies navigating IND filings, orphan drug designation applications, or early Type B meeting requests, regulatory timelines are non-negotiable. A virtual assistant maintains a regulatory calendar tracking submission deadlines, FDA correspondence windows, and internal document review milestones.

The VA logs incoming FDA correspondence in the regulatory affairs tracking system, alerts the responsible team member, and ensures acknowledgment deadlines are not missed. This administrative layer supports regulatory affairs staff without replacing them.

Business Development Meeting Scheduling

BD activity at biotech companies involves coordinating across time zones with pharma partnership contacts, venture investors, academic collaborators, and CRO account managers. Each meeting requires calendar coordination, pre-meeting research compilation, NDA execution reminders, and follow-up action item tracking.

A VA handles the full scheduling workflow — from initial outreach to meeting confirmation to post-meeting follow-up — enabling business development officers to stay focused on relationship strategy rather than logistics.

ROI of Virtual Assistant Support in Biotech Operations

According to Deloitte's 2025 life sciences operations benchmarking report, administrative support functions account for 15 to 22 percent of total operating costs at mid-stage biotech companies. Shifting a portion of those functions to virtual assistant support — at $15 to $30 per hour versus $60,000 to $90,000 for a full-time operations coordinator — delivers measurable cost efficiency without sacrificing responsiveness.

The compounding benefit is that VAs, when properly onboarded with clear SOPs, create documented processes that survive employee turnover — a persistent challenge in the competitive biotech talent market.

For biotech companies that need operational bandwidth without expanding their FTE footprint, virtual assistant support has become a standard component of lean commercial and R&D operations.


Find qualified biotech virtual assistants at Stealth Agents.


Sources

  • BioSpace Industry Operations Survey 2025
  • Deloitte Life Sciences Operations Benchmarking Report 2025
  • BIO Annual Industry Statistics 2025